Multivalent avb3 and metastasis-associated receptor ligands

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/00 (2006.01) A61K 47/48 (2006.01) C07C 279/18 (2006.01) C07C 279/20 (2006.01)

Patent

CA 2338283

The present invention relates to pharmaceutical compounds which are multivalent avb3 receptor/metastasis-associated receptor ligands. The use of these multivalent ligands alone or in conjunction with other agents in pharmaceutical compositions, and in methods for treating conditions mediated by avb3 for the treatment of cancer and other angiogenic diseases, such as diabetic retinopathy, arthritis, hemangiomas, and psoriasis, are also disclosed.

La présente invention se rapporte à des composés pharmaceutiques qui sont des ligands multivalents du récepteur de a¿v?b¿3? et des récepteurs associés aux métastases. L'invention se rapporte également à l'utilisation de ces ligands multivalents, seuls ou associés à d'autres agents, dans des compositions pharmaceutiques et dans des méthodes de traitement des troubles à médiation assurée par a¿v?b¿3? permettant le traitement du cancer et d'autres maladies angiogéniques, telles que la rétinopathie diabétique, l'arthrite, les hémangiomes et le psoriasis.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Multivalent avb3 and metastasis-associated receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Multivalent avb3 and metastasis-associated receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multivalent avb3 and metastasis-associated receptor ligands will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1391109

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.